Digital automation system selected for pharmaceutical production facility
Hanwha Chemical has selected Emerson Process Management to supply and commission its DeltaV digital automation system for a pharmaceutical production facility in Osong Bio-technology Technopolis, Chungcheongbuk-do, Korea. Known as the Eagle Project, the facility will manufacture Hanwha’s biosimilar rheumatoid arthritis drug HD203. The DeltaV system will play a key role in automating the facility’s biotechnology process and support the compliance requirements for FDA approval. Project completion is planned for 2012.
The 2,900-I/O Eagle Project will consolidate its plant process using an integrated system of Emerson’s DeltaV S-Series, AMS Suite asset management software, and audit/change control functionality that supports validation requirements.
Emerson will provide a total of 34 Electronic Marshalling panels, 10 operator workstations installed in the clean room process areas, five manager workstations, and five server stations. The server stations will be used for the process historical data collection, alarm management, complete batch control, and diagnosis of the engineering and control systems.
Process package equipment will be integrated via Profibus DP/MODBUS/OPC communication and the status of all the I/O and devices will be monitored to assess their operating condition.
Emerson’s Electronic Marshalling will not only reduce the site construction time and cost, but also provide a complete solution for future I/O expansion and plant management, because it can be installed in the proximity of devices in the process area and provide the ultimate in flexibility – allowing users to choose I/O type on a channel by channel basis.
Emerson’s AMS Suite asset management software will be used during installation of measurement and control devices to help reduce costs and improve device startup efficiency.
Emerson Process Management
– Edited by Chris Vavra, Control Engineering, www.controleng.com